申请人:——
公开号:US20020132812A1
公开(公告)日:2002-09-19
Compounds of formula (I) which are optionally substituted 2-(&ohgr;,&ohgr;-diarylalkyl)-4,5-dihydro-1H-imidazoles and 2-(&ohgr;,&ohgr;-diarylalkyl)-1,4,5,6-tetrahydropyrimidines and salts thereof with inorganic and organic acids have interesting pharmacological properties. Thus, the compounds are useful in the treatment of type 2 diabetes.
式(I)的化合物,它们是可选择取代的2-(&ohgr;,&ohgr;-二芳基烷基)-4,5-二氢-1H-咪唑和2-(&ohgr;,&ohgr;-二芳基烷基)-1,4,5,6-四氢嘧啶及其与无机和有机酸的盐具有有趣的药理特性。因此,这些化合物在治疗2型糖尿病方面是有用的。